
Keywords: لکوسیت های پلی مورفونیک هسته ای; Post-marketing surveillance; Vaccine safety; Global Vaccine Safety Initiative (GVSI); Adverse events following immunization (AEFI); AEFI; adverse events following immunization; AM; aseptic meningitis; CI; Confidence Interval; CSF; cerebrospinal fluid; EMC